Dysplasia

-plasia
Anaplasia – dedifferentiation
Hyperplasia – physiological proliferation Increase in number of cells
Neoplasia – abnormal proliferation
Dysplasia – maturation abnormality
Metaplasia – cell type conversion
Prosoplasia – cell type develops new function
Desmoplasia – connective tissue growth

Dysplasia (from the Greek δυσπλασία "malformation", δυσ- "mal-" + πλάθω "to create, to form"), is a term used in pathology to refer to an abnormality of development.^[1] This generally consists of an expansion of immature cells, with a corresponding decrease in the number and location of mature cells. Dysplasia is often indicative of an early neoplastic process. The term dysplasia is typically used when the cellular abnormality is restricted to the originating tissue, as in the case of an early, in-situ neoplasm.

Dysplasia, in which cell maturation and differentiation are delayed, can be contrasted with metaplasia, in which cells of one mature, differentiated type are replaced by cells of another mature, differentiated type.

The terms hip dysplasia and fibrous dysplasia also refer to abnormal development, but at a more macroscopic level.

Contents 1 Examples 2 Microscopic changes 3 Dysplasia vs. carcinoma in situ vs. invasive carcinoma 4 References

Examples

For example, epithelial dysplasia of the cervix (cervical intraepithelial neoplasia – a disorder commonly detected by an abnormal pap smear) consists of an increased population of immature (basal-like) cells which are restricted to the mucosal surface, and have not invaded through the basement membrane to the deeper soft tissues. Analogous conditions include vaginal intraepithelial neoplasia and vulvar intraepithelial neoplasia.

Myelodysplastic syndromes, or dysplasia of blood-forming cells, show increased numbers of immature cells in the bone marrow, and a decrease in mature, functional cells in the blood.

Microscopic changes

Dysplasia is characterised by four major pathological microscopic changes:

1. Anisocytosis (cells of unequal size)
2. Poikilocytosis (abnormally shaped cells)
3. Hyperchromatism
4. Presence of mitotic figures (an unusual number of cells which are currently dividing).

Dysplasia vs. carcinoma in situ vs. invasive carcinoma

These terms are related since they represent the three steps in the progression of many malignant neoplasms (cancers) of epithelial tissues. The likelihood of developing carcinoma is related to the degree of dysplasia.^[2]

• Dysplasia is the earliest form of pre-cancerous lesion which pathologists can recognize in a pap smear or in a biopsy. Dysplasia can be low grade or high grade (see "Carcinoma in situ," below). The risk of low grade dysplasia transforming into high grade dysplasia, and eventually cancer, is low. Treatment is usually straightforward. High grade dysplasia represents a more advanced progression towards malignant transformation.
• Carcinoma in situ, meaning "cancer in place", represents the transformation of a neoplastic lesion to one in which cells undergo essentially no maturation, and thus may be considered cancer-like. In this state, epithelial cells have lost their tissue identity and have reverted back to a primitive cell form that grows rapidly and with abnormal regulation for the tissue type. However, this form of cancer remains localized, and has not invaded past the basement membrane into tissues below the surface.
• Invasive carcinoma is the final step in this sequence. It is a cancer which has invaded beyond the basement membrane and has potential to metastasize (spread to other parts of the body). Invasive carcinoma can usually be treated, but not always successfully. However, if it is left untreated, it is almost always fatal.

References

• Noel Weidner (editor), Richard Cote, Saul Suster, Lawrence Weiss (2003). Modern Surgical Pathology. London: W.B. Saunders. ISBN 0-7216-7253-1. OCLC 50244347. 
• Ramzi S. Cotran, Vinay Kumar, Tucker Collins (Editor) (1999). Robbins Pathologic Basis of Disease (6th ed.). London: W.B. Saunders. ISBN 0-7216-7335-X. OCLC 39465455. 

Pathology: Tumor, Neoplasm, Cancer, and Oncology (C00–D48, 140–239) Conditions Benign tumors Hyperplasia · Cyst · Pseudocyst · Hamartoma Malignant progression Dysplasia · Carcinoma in situ · Cancer · Metastasis Topography Head/Neck (Oral, Nasopharyngeal) · Digestive system · Respiratory system · Bone · Skin · Blood · Urogenital · Nervous system · Endocrine system Histology Carcinoma · Sarcoma · Papilloma · Adenoma Other Precancerous condition · Paraneoplastic syndrome Staging/grading TNM · Ann Arbor · Prostate cancer staging · Gleason Grading System · Dukes classification Carcinogenesis Cancer cell · Carcinogen · Tumor suppressor genes/oncogenes · Clonally transmissible cancer · Oncovirus · Cancer bacteria Misc. Research · List of oncology-related terms · Cancer pain M: NEO tsoc, mrkr tumr, epon, para drug (L1i/1e/V03)

Medicine: Pathology Principles of pathology Disease/Medical condition (Infection, Neoplasia) · Hemodynamics (Ischemia) · Inflammation · Wound healing Cell death: Necrosis (Liquefactive necrosis, Coagulative necrosis, Caseous necrosis, Fat necrosis) · Apoptosis · Pyknosis · Karyorrhexis · Karyolysis Cellular adaptation: Atrophy · Hypertrophy · Hyperplasia · Dysplasia · Metaplasia (Squamous, Glandular) accumulations: pigment (Hemosiderin, Lipochrome/Lipofuscin, Melanin) · Steatosis Anatomical pathology Surgical pathology · Cytopathology · Autopsy · Molecular pathology · Forensic pathology · Dental pathology  Gross examination · Histopathology · Immunohistochemistry · Electron microscopy · Immunofluorescence · Fluorescent in situ hybridization Clinical pathology Clinical chemistry · Hematopathology · Transfusion medicine · Medical microbiology · Diagnostic immunology  · Immunopathology Enzyme assay · Mass spectrometry · Chromatography · Flow cytometry · Blood bank · Microbiological culture · Serology Specific conditions Myocardial infarction